We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$23.2B
AUM Growth
+$1.19B
Cap. Flow
-$399M
Cap. Flow %
-1.72%
Top 10 Hldgs %
11.44%
Holding
1,418
New
187
Increased
581
Reduced
380
Closed
112

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$53.1M
2
EXC icon
Exelon
EXC
+$52.7M
3
ORCL icon
Oracle
ORCL
+$42.5M
4
PH icon
Parker-Hannifin
PH
+$37.9M
5
RYAAY icon
Ryanair
RYAAY
+$37.8M

Top Sells

Rank Stock Value
1
FTI icon
TechnipFMC
FTI
+$67.8M
2
ECL icon
Ecolab
ECL
+$56.9M
3
FFIV icon
F5
FFIV
+$46.6M
4
RTX icon
RTX Corp
RTX
+$44.1M
5
GIS icon
General Mills
GIS
+$36.2M

Sector Composition

Rank Sector Weight
1 Technology 17.9%
2 Healthcare 15.74%
3 Financials 11.81%
4 Industrials 9.62%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COO icon
151
Cooper Companies
COO
$14.2B
$46M 0.2%
775,876
+22,900
+3% +$1.4M
PNC icon
152
PNC Financial Services
PNC
$99.1B
$45.4M 0.2%
337,039
+6,903
+2% +$886K
MDLZ icon
153
Mondelez International
MDLZ
$83.4B
$45.1M 0.19%
1,110,357
-19,401
-2% -$824K
ITW icon
154
Illinois Tool Works
ITW
$84.1B
$44.5M 0.19%
300,701
+10,108
+3% +$1.44M
IVE icon
155
iShares S&P 500 Value ETF
IVE
$49.1B
$43.8M 0.19%
406,241
+8,600
+2% +$910K
AET
156
DELISTED
Aetna Inc
AET
$43.7M 0.19%
274,863
+39,125
+17% +$6.11M
TNL icon
157
Travel + Leisure Co
TNL
$4.76B
$43.4M 0.19%
912,055
-45,047
-5% -$2.06M
ELV icon
158
Elevance Health
ELV
$81.5B
$43.4M 0.19%
228,388
+24,916
+12% +$4.74M
WMT icon
159
Walmart Inc
WMT
$909B
$42.9M 0.18%
1,647,876
+43,908
+3% +$1.15M
ILCV icon
160
iShares Morningstar Value ETF
ILCV
$1.31B
$42.9M 0.18%
860,672
-22,000
-2% -$1.07M
BNY
161
Bank of New York Mellon
BNY
$103B
$42.4M 0.18%
800,399
+106,681
+15% +$5.6M
SNPS icon
162
Synopsys
SNPS
$71.6B
$42.2M 0.18%
523,692
-180,836
-26% -$14M
APD icon
163
Air Products & Chemicals
APD
$65.5B
$42.1M 0.18%
278,689
-62,848
-18% -$9.21M
REGN icon
164
Regeneron Pharmaceuticals
REGN
$72.9B
$41.8M 0.18%
93,461
-18,450
-16% -$8.78M
LOW icon
165
Lowe's Companies
LOW
$121B
$41.7M 0.18%
521,931
-51,182
-9% -$3.92M
ST icon
166
Sensata Technologies
ST
$6.69B
$41.7M 0.18%
867,598
+179,265
+26% +$8.1M
VRTX icon
167
Vertex Pharmaceuticals
VRTX
$123B
$41.7M 0.18%
274,198
+103,149
+60% +$15.5M
TRV icon
168
Travelers Companies
TRV
$81.1B
$41.5M 0.18%
338,349
-23,781
-7% -$2.97M
VTV icon
169
Vanguard Value ETF
VTV
$188B
$41.5M 0.18%
415,301
-8,000
-2% -$783K
CI icon
170
Cigna
CI
$78.4B
$41.2M 0.18%
220,462
+5,870
+3% +$1.05M
ES icon
171
Eversource Energy
ES
$28.1B
$40.9M 0.18%
677,037
-257,882
-28% -$15.9M
AMBA icon
172
Ambarella
AMBA
$3.04B
$40.9M 0.18%
834,078
+125,972
+18% +$6.21M
BLK icon
173
Blackrock
BLK
$167B
$40.7M 0.18%
90,952
+8,997
+11% +$3.84M
NKE icon
174
Nike
NKE
$64.1B
$40.4M 0.17%
778,365
-224,091
-22% -$12.6M
VGK icon
175
Vanguard FTSE Europe ETF
VGK
$30.1B
$39.5M 0.17%
676,750

Similar funds

Axa's Q3 2017 Portfolio in Review

As of Q3 2017, Axa held 1,418 positions worth $23.2B, up 5.4% from $22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Axa's Q3 2017 filing shows 187 new, 581 increased, 380 reduced and 112 closed positions. Its largest new stake was Ryanair: 836,448 shares worth $35.3M. The largest sale was TechnipFMC, an estimated $67.8M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q3 2017 buy was Ryanair: 836,448 shares worth $35.3M.
  • Axa added most to General Motors in Q3 2017, an estimated $53.1M increase.
  • Axa's biggest Q3 2017 reduction was TechnipFMC, cutting an estimated $67.8M.
  • Axa fully exited F5 in Q3 2017, selling an estimated $46.6M.
  • Axa's ten largest holdings make up 11% of its $23.2B portfolio in Q3 2017.
  • Axa opened 187 new positions and closed 112 in Q3 2017.
  • Axa's portfolio value rose 5.4% quarter-over-quarter to $23.2B.

Based on Axa's 13F filing for Q3 2017, filed 13 Nov 2017.